Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy
Clinical trial NCT06607796 · RECRUITING
Trial details
- NCT number
- NCT06607796
- Sponsor
- Zhou Chengzhi
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.